Author: Lennard YW Lee
-
Clinical trials- a ship changing course in the midst of a storm- decentralisation
Our country is now in a new phase of our national research infrastructure- the Hyperacceleration Era. It will move us from concept to clinical care at a speed we haven’t seen before. This will transform patient outcomes for those with cancer. This is great news.
-
Can we be positive about cancer advances in 2023?
WHAT CAN CANCER PATIENTS EXPECT IN 2023? Many of us have faced significant challenges and the UK has faced a difficult 12 months. However, can we be optimistic about the future of cancer in 2023?
-
Researchers study combining antibody treatment with COVID-19 vaccination in immunocompromised patients
People in the UK with impaired immune systems will have the opportunity to take part in a clinical trial investigating COVID-19 vaccinations in combination with Evusheld, a new antibody treatment used for the prevention of COVID-19 infection.
-
RESEARCH EXCELLENCE PRIZE- ONCOVID
Imperial’s Oncovid consortium has been awarded a national award by the UK Coronavirus Cancer Programme (UKCCP) for their efforts in protecting cancer patients during the coronavirus pandemic.
-
WHAT MEDICAL STUDENTS GAIN FROM INVOLVEMENT IN RESEARCH
Our country is now in a new phase of our national research infrastructure- the Hyperacceleration Era. It will move us from concept to clinical care at a speed we haven’t seen before. This will transform patient outcomes for those with cancer. This is great news.
-
IS CANCER RESEARCH HYPERACCELERATED?
Our country is now in a new phase of our national research infrastructure- the Hyperacceleration Era. It will move us from concept to clinical care at a speed we haven’t seen before. This will transform patient outcomes for those with cancer. This is great news.
-
Unlocking the data potential within the United Kingdom for population scale research
You are probably seeing quite a lot about the #forgotten500k in the newspapers and social media and you might be wondering what it is about and what are we doing about it? – Dr Lennard lee
-
What is the #forgotten500k and why does it matter to cancer patients?
You are probably seeing quite a lot about the #forgotten500k in the newspapers and social media and you might be wondering what it is about and what are we doing about it? – Dr Lennard lee
-
Nominations for research excellence now open
Nominations are now open to individuals, groups, and regions who you feel deserve special recognition for their ongoing performances and efforts in making the UKCCP a success.
-
Did we get it right? Lessons learnt in the last 6 months
Back in November 2021, our team at the UK Coronavirus cancer programme went public with the provocative statement, “As COVID-19 cases surge despite mass vaccination, it’s time to focus on the vulnerable”.